AstraZeneca Aktie
150,95
EUR
-1,40
EUR
-0,92
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 24.10.19 | AstraZeneca Sell | UBS AG | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.10.19 | AstraZeneca Reduce | HSBC | |
| 15.10.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.10.19 | AstraZeneca Reduce | HSBC | |
| 01.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 30.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.09.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca overweight | Barclays Capital | |
| 10.09.19 | AstraZeneca Sell | UBS AG | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.08.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | Barclays Capital | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca overweight | Barclays Capital | |
| 26.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.07.19 | AstraZeneca Sell | UBS AG | |
| 25.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 27.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 17.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
Werbung
Werbung